Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - AMYRIS, INC. | Financial_Report.xls |
| EX-32.02 - EXHIBIT 32.02 - AMYRIS, INC. | amyris201410-kex3202.htm |
| EX-31.01 - EXHIBIT 31.01 - AMYRIS, INC. | amyris201410-kex3101.htm |
| EX-31.02 - EXHIBIT 31.02 - AMYRIS, INC. | amyris201410-kex3102.htm |
| EX-32.01 - EXHIBIT 32.01 - AMYRIS, INC. | amyris201410-kex3201.htm |
| EX-23.01 - EXHIBIT 23.01 - AMYRIS, INC. | amyris201410-kex2301.htm |
| EX-23.02 - EXHIBIT 23.02 - AMYRIS, INC. | amyris201410-kex2302.htm |
| EX-10.03 - EXHIBIT 10.03 - AMYRIS, INC. | amyris201410-kex1003darpam.htm |
| EX-21.01 - EXHIBIT 21.01 - AMYRIS, INC. | amyris201410-kex2101listsu.htm |
| EX-10.68 - EXHIBIT 10.68 - AMYRIS, INC. | amyris201410-kex1068raffia.htm |
| 10-K - 10-K - AMYRIS, INC. | amrs201410k.htm |
| EX-99.1 - EXHIBIT 99.1 - AMYRIS, INC. | amyris201410-kex991.htm |
MODIFICATION
TO
TECHNOLOGY INVESTMENT AGREEMENT
BETWEEN
AMYRIS, INC.,
5885 HOLLIS STREET
SUITE 100
EMERYVILLE, CALIFORNIA 94608
AND
THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY
675 NORTH RANDOLPH STREET
ARLINGTON, VA 22203-2114
CONCERNING
IMPROVING DNA ASSEMBLY AND INTEGRATION ACROSS PLATFORMS WITH
BETTER SYSTEMS AND TOOLS
(LIVING FOUNDRIES)
Agreement No.: HR0011-12-3-0006
Modification No.: P00014
Purchase Request No.: N/A
Total Amount of the Agreement: $8,653,604
Phase 1: $3,358,334
Phase 2 (Option): $5,295,269
Total Estimated Government Funding: $7,734,309
Phase 1: $3,022,501
Phase 2 (Option): $4,711,808
Contactor Share Contribution: $919,295
Phase 1: $335,834
Phase 2 (Option): $583,461
Funds Obligated By This Modification: $0
Total Funds Obligated To Date: $7,734,309
Authority: Article III(C)(1)
HR0011-12-3-0006 P00014 Page 2 of 2 | ||
The purpose of this modification is to clarify the ACRN (long line of of accounting ) referenced in Modification P00013. As such, the following administrative information (pertaining to Modification No. P00013) applies:
1. Per Modification No. P00013, Article V, “Obligation and Payment,” paragraph C, “Accounting and Appropriation Data,” is revised to reflect the inclusion of the $80,000 (PR No. HR0011412252) provided to Milestone No. 16. The Line of Accounting is shown below (as reflected in the conformed agreement provided as Enclosure 1 to Modification No. P00013):
ACRN AD: 012199 097 0400 000 N 20142015 D 1320 BLTM6 2014.MBT-02.CORE.A DARPA 255 $80,000
2. As noted above, this modification is administrative in nature and is provided only to clarify the accounting line/funding what was added to the agreement via Modification No. P00013. This modification effects no changes to the agreement – the Conformed Copy of the agreement provided as Enclosure 1 to Modification No. P00013 remains unchanged (the above noted accounting line/funding information is captured therein).
3. All terms and provisions of Agreement No. HR0011-12-3-0006 remain in full force and effect.
FOR THE DEFENSE ADVANCED RESEARCH PRODUCTS AGENCY | ||
/s/ Michael D. Blackstone 2014.11.25 | ||
(Signature & Date) | ||
Michael D. Blackstone | ||
Agreements Officer | ||